Blum (BLMH) 10-Q 14 May 24 2024 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2024	May 10, 2024
Document Information [Line Items]
Entity Central Index Key	0001996210
Entity Registrant Name	BLUM HOLDINGS, INC.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	000-54258
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	93-3735199
Entity Address, Address Line One	3242 S. Halladay Street, Suite 202
Entity Address, City or Town	Santa Ana
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92705
City Area Code	888
Local Phone Number	909-5564
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,499,105

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and Cash Equivalents	$ 1,175	$ 862
Accounts Receivable, Net of Allowances of $150 at both March 31, 2024 and December 31, 2023	761	1,004
Inventory	1,663	1,700
Prepaid Expenses & Other Assets	589	470
Notes Receivable	650	645
Assets Related to Discontinued Operations	16	12
Total Current Assets	4,854	4,693
Property, Equipment and Leasehold Improvements, Net	9,690	9,766
Operating Lease Right-of-Use Assets	8,508	8,965
Total Intangible Assets, Net	1,350	1,359
Goodwill	3,585	3,585
Other Assets	2,824	1,541
Investments	1,083	2,067
Long-Term Assets Related to Discontinued Operations	69	95
TOTAL ASSETS	31,963	32,071
Current Liabilities:
Accounts Payable & Accrued Liabilities	26,067	23,218
Current Portion of Notes Payable	22,573	22,593
Income Taxes Payable	17,076	16,637
Liabilities Related to Discontinued Operations	0	100
Total Current Liabilities	65,716	62,548
Notes Payable, Net of Discounts	6,472	6,485
Deferred Tax Liabilities	140	112
Operating Lease Liabilities	8,272	8,622
Long-Term Liabilities Related to Discontinued Operations	0	0
TOTAL LIABILITIES	80,600	77,767
COMMITMENTS AND CONTINGENCIES (Note 18)
STOCKHOLDERS’ DEFICIT:
Preferred Stock, Convertible Series V, par value $0.001: 25,000,000 shares authorized; 14,071,431 shares outstanding as of March 31, 2024 and December 31, 2023	1	1
Common Stock, par value $0.001: 990,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 8,499,105 and 8,509,384 shares outstanding as of March 31, 2024 and December 31, 2023, respectively	8	9
Additional Paid-In Capital	408,584	408,473
Accumulated Deficit	(457,230)	(454,179)
TOTAL STOCKHOLDERS’ DEFICIT	(48,637)	(45,696)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 31,963	$ 32,071

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounts receivable, allowance	$ 150	$ 150
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	25,000,000	25,000,000
Preferred stock, outstanding (in shares)	14,071,431	14,071,431
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	990,000,000	990,000,000
Common stock, outstanding (in shares)	8,499,105	8,509,384

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue	$ 6,782	$ 8,617
Cost of Goods Sold	3,174	3,923
Gross Profit	3,608	4,694
Operating Expenses:
Selling, General & Administrative	6,099	5,549
Total Operating Expenses	6,099	5,549
Loss from Operations	(2,491)	(855)
Other Income (Expense):
Interest Expense, Net	(1,017)	(1,024)
Gain on Extinguishment of Debt	0	3,026
Realized Loss on Investments	0	(61)
Unrealized Gain on Long-Term Investments	417	0
Other Income	88	0
Total Other Income (Expense)	(512)	1,941
Income (Loss) from Continuing Operations Before Provision for Income Taxes	(3,003)	1,086
Provision for Income Tax (Expense) Benefit for Continuing Operations	(52)	(658)
Net Income (Loss) from Continuing Operations	(3,055)	428
Income (Loss) from Discontinued Operations Before Provision for Income Taxes	4	(18)
Provision for Income Tax for Discontinued Operations	0	0
Net Income (Loss) from Discontinued Operations	4	(18)
Net Income (Loss)	$ (3,051)	$ 410
Net Income (Loss) from Continuing Operations per Common Share - Basic (in dollars per share)	$ (0.31)	$ 0.05
Net Income (Loss) from Continuing Operations per Common Share - Diluted (in dollars per share)	$ (0.31)	$ 0.05
Weighted-Average Shares Outstanding - Basic (in shares)	9,909,072	8,166,859
Weighted-Average Shares Outstanding - Diluted (in shares)	9,909,072	8,352,745

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Series A Preferred Stock [Member]	Common Stock [Member]	Treasury Stock, Common [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2022	0	6,795,136
Balance at Dec. 31, 2022	$ 0	$ 701	$ (808)	$ 403,619	$ (440,049)	$ (36,537)
NET INCOME (LOSS)	0	0	0	0	410	410
Stock Option Expense	$ 0	$ 0	0	99	0	99
Stock Compensation - Services Expense (in shares)	0	161,812
Stock Compensation - Services Expense	$ 0	$ 16	0	340	0	356
Stock Issued for Cash (in shares)	14,071,431	0
Stock Issued for Cash	$ 1	$ 0	0	1,969	0	1,970
Forfeiture of Common Stock	$ 0	$ 0	(2)	2	0	0
Balance (in shares) at Mar. 31, 2023	14,071,431	6,956,948
Balance at Mar. 31, 2023	$ 1	$ 717	(810)	406,029	(439,639)	(33,702)
Balance (in shares) at Dec. 31, 2023	14,071,431	8,509,384
Balance at Dec. 31, 2023	$ 1	$ 9	0	408,473	(454,179)	(45,696)
NET INCOME (LOSS)	$ 0	$ 0	0	0	(3,051)	(3,051)
Cancellation of Shares (in shares)	0	(10,279)
Cancellation of Shares	$ 0	$ (1)	0	1	0	0
Stock Option Expense	$ 0	$ 0	0	110	0	110
Balance (in shares) at Mar. 31, 2024	14,071,431	8,499,105
Balance at Mar. 31, 2024	$ 1	$ 8	$ 0	$ 408,584	$ (457,230)	$ (48,637)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ (3,051)	$ 410
Less: Net Income (Loss) from Discontinued Operations	4	(18)
Net Income (Loss) from Continuing Operations	(3,055)	428
Adjustments to Reconcile Net Income (Loss) to Net Cash Used in Operating Activities:
Deferred Income Tax Benefit	28	0
Bad Debt Expense (Recoveries)	2	(7)
Gain from Settlement of Liabilities	0	(1,507)
Realized Loss on Investments	0	61
Gain on Extinguishment of Debt	0	(3,026)
Non-Cash Interest (Income) Expense, Net	(5)	326
Depreciation and Amortization	94	775
Amortization of Operating Lease Right-of-Use Asset	457	491
Stock-Based Compensation	110	455
Unrealized Gain on Investments	(417)	0
Change in Operating Assets and Liabilities:
Accounts Receivable	241	(349)
Inventory	37	(634)
Prepaid Expenses and Other Current Assets	(119)	183
Other Assets	(1)	(64)
Accounts Payable and Accrued Expenses	2,002	832
Operating Lease Liabilities	(350)	(212)
Net Cash Used in Operating Activities - Continuing Operations	(976)	(2,248)
Net Cash Provided by Operating Activities - Discontinued Operations	27	36
NET CASH USED IN OPERATING ACTIVITIES	(949)	(2,212)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of Property and Equipment	(9)	(153)
Proceeds from Notes Receivable	0	634
Proceeds from Sale of Investments	1,300	149
Net Cash Provided by Investing Activities - Continuing Operations	1,291	630
Net Cash Provided by Investing Activities - Discontinued Operations	0	0
NET CASH PROVIDED BY INVESTING ACTIVITIES	1,291	630
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of Debt Principal	(29)	(224)
Proceeds from Issuance of Preferred Stock	0	1,970
Net Cash Provided by (Used in) Financing Activities - Continuing Operations	(29)	1,746
Net Cash Used in Financing Activities - Discontinued Operations	0	0
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	(29)	1,746
NET CHANGE IN CASH	313	164
Cash at Beginning of Period	862	1,200
Cash Reclassed to Discontinued Operations	0	0
CASH AT END OF PERIOD	1,175	1,364
SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:
Cash Paid for Interest	490	179
SUPPLEMENTAL DISCLOSURE FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:
Reclass of Accrued Interest to Principal	$ 0	$ 1,896

Note 1 - Description of Busines

Note 1 - Description of Business	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	NOTE 1 DESCRIPTION OF BUSINESS Blum Holdings, Inc. (“Blüm” or the “Company”) is a cannabis company with operations in retail and distribution throughout California, with an emphasis on providing the highest quality of medical and adult use cannabis products. The Company is home to Korova, a brand of high potency products across multiple product categories, currently available in California. The Company operates Blüm OC, a premier cannabis dispensary in Orange County, California. The Company also owns dispensaries in California which operate as The Spot in Santa Ana, Blüm in Oakland, and Blüm in San Leandro. Blum Holdings, Inc. is a holding company with the following subsidiaries: • Unrivaled Brands, Inc., a Nevada corporation (“Unrivaled”) • Black Oak Gallery, a California corporation (“Black Oak” or “Blüm Oakland”) • Blüm San Leandro, a California corporation (“Blüm San Leandro”) • 2705 • 3242 • 3242 • Halladay Holding, LLC, a California limited liability company (“Halladay”) • People’s First Choice, LLC, a California limited liability company (“Blüm OC”) • People’s Costa Mesa, LLC, a California limited liability company References in this document to the “Company”, “Blüm”, “we”, “us”, or “our” are intended to mean Blum Holdings, Inc., individually, or as the context requires, collectively with its subsidiaries on a consolidated basis. Corporate Reorganization On January 12, 2024, October 9, 2023 ( The Reorganization Agreement provides that at the effective time of the Reorganization, on January 12, 2024, one one one February 12, 2024, Additionally, effective January 12, 2024, ( x Effective January 12, 2024, 1

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and with the instructions to U.S. Securities and Exchange Commission (“SEC”) Form 10 10 X 1933 810, Consolidation, The typical condition for a controlling financial interest ownership is holding a majority of the voting interests of an entity; however, a controlling financial interest may not 810 not not All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of March 31, 2024 December 31, 2023 March 31, 2024 2023 not December 31, 2023 December 31, 2023 December 31, 2023 not Going Concern The Company incurred a pre-tax net loss from continuing operations of $3.0 million for the three March 31, 2024 three March 31, 2023 March 31, 2024 December 31, 2023 March 31, 2024 2024 may not no The Company will be required to raise additional funds through public or private financing, additional collaborative relationships or other arrangements until it is able to raise revenues to a point of positive cash flow. The Company is evaluating various options to further reduce its cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling common stock. There is no The issuance of additional securities may no not not The risks and uncertainties surrounding the Company's ability to continue to raise capital and its limited capital resources raise substantial doubt as to the Company's ability to continue as a going concern for twelve The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. In an effort to achieve liquidity that would be sufficient to meet all of its commitments, the Company has undertaken a number of actions, including minimizing capital expenditures and reducing recurring expenses. However, management believes that even after taking these actions, the Company will not Significant Accounting Policies The significant accounting policies and critical estimates applied by the Company in these interim unaudited consolidated financial statements are the same as those applied in the Company’s audited consolidated financial statements and accompanying notes included in the Company’s 2023 10 March 31, 2024 Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the dates of the financial statements and the reported amounts of total net revenue and expenses in the reporting periods. The Company regularly evaluates estimates and assumptions related to revenue recognition, inventory valuation, stock-based compensation expense, goodwill and purchased intangible asset valuations, derivative liabilities, deferred income tax asset valuation allowances, uncertain tax positions, tax contingencies, litigation and other loss contingencies. These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenue, costs and expenses that are not may Income and Loss Per Common Share In accordance with the provisions of ASC 260, Earnings Per Share , not three March 31, 2024 2023 three March 31, 2023 Dilutive securities that are not Three Months Ended March 31, 2024 2023 Common Stock Warrants 1,461,997 1,011,618 Common Stock Options 369,301 433,316 1,831,298 1,444,934 Recently Adopted Accounting Standards In June 2022, 2022 03, Fair Value Measurements Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820 2022 03 not not December 15, 2023, January 1, 2024 not Recently Issued Accounting Standards In July 2023, 2023 03, Presentation of Financial Statement (Topic 205 220 480 505 718 No. 120, not no In October 2023, 2023 06, Disclosure Improvements X 2023 06 X not In November 2023, 2023 07, Segment Reporting (Topic 280 280 December 15, 2023, December 15, 2024. In December 2023, 2023 09, Income Taxes (Topic 740 December 15, 2024.

Note 3 - Concentrations of Busi

Note 3 - Concentrations of Business and Credit Risk	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	NOTE 3 CONCENTRATIONS OF BUSINESS AND CREDIT RISK The Company maintains cash balances in several financial institutions that are insured by either the Federal Deposit Insurance Corporation or the National Credit Union Association up to certain federal limitations. At times, the Company’s cash balance exceeds these federal limitations, and it maintains significant cash on hand at certain of its locations. The Company has not nil March 31, 2024 December 31, 2023 The Company provides credit in the normal course of business to customers located throughout the U.S. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends, and other information. There were no customers that comprised more than 10.0% three March 31, 2024 2023 The Company sources cannabis products for retail from various vendors. However, as a result of regulations in the State of California, the Company’s California retail operations must use vendors licensed by the State. As a result, the Company is dependent upon the licensed vendors in California to supply products. If the Company is unable to enter into relationships with sufficient members of properly licensed vendors, the Company’s sales may three March 31, 2024 2023 not may

Note 4 - Inventory

Note 4 - Inventory	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 4 INVENTORY Raw materials consist of materials and packaging for manufacturing of products owned by the Company. Finished goods consists of cannabis products sold in retail and distribution. Inventory consisted of the following: (in thousands) March 31, December 31, 2024 2023 Raw Materials $ 642 $ 647 Finished Goods 1,021 1,053 Total Inventory $ 1,663 $ 1,700

Note 5 - Investments

Note 5 - Investments	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Investment [Text Block]	NOTE 5 INVESTMENTS Mystic Holdings In September 2023, 321, 1 March 31, 2024 three March 31, 2024 The following tables present the Company’s financial instruments that are measured and recorded at fair value on the Company’s consolidated balance sheets on a recurring basis: (in thousands) March 31, 2024 Amount Level 1 Level 2 Level 3 Investment in Mystic Holdings, Inc. $ 1,083 $ 1,083 $ — $ — Total $ 1,083 $ 1,083 $ — $ — (in thousands) December 31, 2023 Amount Level 1 Level 2 Level 3 Investment in Mystic Holdings, Inc. $ 667 $ 667 $ — $ — Total $ 667 $ 667 $ — $ —

Note 6 - Property, Equipment an

Note 6 - Property, Equipment and Leasehold Improvements	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 6 PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS Property, equipment, and leasehold improvements consisted of the following: (in thousands) March 31, December 31, 2024 2023 Land and Building $ 7,581 $ 7,581 Furniture and Equipment 354 354 Computer Hardware 343 343 Leasehold Improvements 5,495 5,487 Vehicles 57 57 Construction in Progress 908 908 Subtotal 14,738 14,730 Less Accumulated Depreciation (5,048 ) (4,964 ) Property, Equipment and Leasehold Improvements, Net $ 9,690 $ 9,766 Depreciation expense related to continuing operations was $0.09 million and $0.12 million for the three March 31, 2024 2023 All property, equipment and leasehold improvements related to discontinued operations are separately presented from the consolidated balance sheets as of March 31, 2024 December 31, 2023 Note 15 - Discontinued Operations

Note 7 - Intangible Assets

Note 7 - Intangible Assets	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	NOTE 7 INTANGIBLE ASSETS Intangible assets consisted of the following: (in thousands) March 31, 2024 December 31, 2023 Estimated Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Carrying Value Gross Carrying Amount Accumulated Amortization Net Carrying Value Amortizing Intangible Assets: Trademarks and Patent 2 to 8 $ 4,500 $ (4,500 ) $ — $ 4,500 $ (4,491 ) $ 9 Total Amortizing Intangible Assets 4,500 (4,500 ) — 4,500 (4,491 ) 9 Non-Amortizing Intangible Assets: Trade Name Indefinite 1,350 — 1,350 1,350 — 1,350 Total Non-Amortizing Intangible Assets 1,350 — 1,350 1,350 — 1,350 Total Intangible Assets, Net $ 5,850 $ (4,500 ) $ 1,350 $ 5,850 $ (4,491 ) $ 1,359 Amortization expense related to continuing operations was $0.01 million and $0.56 million for the three March 31, 2024 2023

Note 8 - Goodwill

Note 8 - Goodwill	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Goodwill Disclosure [Text Block]	NOTE 8 GOODWILL Goodwill is assigned to the reporting unit, which is the operating segment level or one November 1, may March 31, 2024 December 31, 2023

Note 9 - Accounts Payable and A

Note 9 - Accounts Payable and Accrued Liabilities	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 9 ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payable and accrued liabilities consisted of the following: (in thousands) March 31, December 31, 2024 2023 Accounts Payable $ 14,606 $ 13,848 Tax Liabilities 2,584 1,445 Accrued Payroll and Benefits 273 494 Current Lease Liabilities 1,963 1,914 Accrued Interest 1,953 1,421 Other Accrued Expenses 4,688 4,096 Total Accounts Payable and Accrued Expenses $ 26,067 $ 23,218

Note 10 - Leases

Note 10 - Leases	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	NOTE 10 LEASES A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. Operating lease right-of-use assets are separately stated while current and long-term lease liabilities are included in accounts payable and accrued liabilities and a separate item, respectively, on the Company’s consolidated balance sheets. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Most operating leases contain renewal options that provide for rent increases based on prevailing market conditions. The terms used to calculate the right-of-use assets for certain properties include the renewal options that the Company is reasonably certain to exercise. The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not not not The Company occupies office and other facilities under lease agreements that expire at various dates. In addition, office, production and transportation equipment are leased under agreements that expire at various dates. The Company does not three March 31, 2024 2023 March 31, 2024 2023 not As of March 31, 2024 December 31, 2023 (in thousands) March 31, December 31, 2024 2023 Operating Lease Right-of-Use Assets $ 8,508 $ 8,965 Operating Lease Liabilities $ 10,235 $ 10,536 The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use assets: Three Months Ended March 31, March 31, 2024 2023 Weighted Average Remaining Lease Term (Years) 8.3 8.6 Weighted Average Discount Rate 11.4 % 11.4 %

Note 11 - Notes Payable

Note 11 - Notes Payable	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 11 NOTES PAYABLE Notes payable consisted of the following: (in thousands) March 31, December 31, 2024 2023 Promissory note dated July 27, 2021, issued to Arthur Chan, which matures July 26, 2024 8 $ 2,500 $ 2,500 Unsecured promissory note dated December 28, 2022 due to a related party. The interest rate on the note is 1 December 28, 2027 154 154 Promissory note dated October 1, 2021, issued to Matthew Guild as part of the SilverStreak Solutions acquisition. The interest rate on the note was 10.0 March 2028 261 264 Promissory note dated October 1, 2021, issued to Sterling Harlan as part of the SilverStreak Solutions acquisition. The interest rate on the note was 10.0 March 2028 1,044 1,058 Secured promissory notes dated March 6, 2023 issued to People's California, LLC, which matures in March 2028 10.0 5.0 10.0 22,200 22,200 Promissory note dated May 1, 2019, assumed by the Company on July 1, 2021 in connection with the purchase of real property, from a related party. The note matures on May 15, 2039 9.9 2,794 2,813 Notes Payable - Promissory Notes 28,953 28,989 Vehicle Loans 6 7 Less: Short-Term Debt (22,573 ) (22,593 ) Plus: Debt Premium, Net 86 82 Net Long-Term Debt $ 6,472 $ 6,485 Promissory Note Related to People's California, LLC On March 6, 2023, May 17, 2023, July 10, 2023, July 6, 2023 June 2023. March 31, 2024 December 31, 2023 March 31, 2024

Note 12 - Stockholders' Deficit

Note 12 - Stockholders' Deficit	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Equity [Text Block]	NOTE 12 STOCKHOLDERS' DEFICIT Series V Preferred Stock In December 2022, ten first ten second one two one tenth 1/10 th January 12, 2024 In January 2023, December 30, 2022 one tenth 1/10 th one two Series N Preferred Stock In February 2023, first first one January 12, 2024. Common Stock The Company authorized 990,000,000 shares of common stock with $0.001 par value per share. As of March 31, 2024 December 31, 2023

Note 13 - Stock-based Compensat

Note 13 - Stock-based Compensation	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	NOTE 13 STOCK-BASED COMPENSATION Equity Incentive Plans As a result of the Reorganization on January 12, 2024, 2016 “2016 2018 “2018 2019 “2019 The following table contains information about the Company's equity incentive plans as of March 31, 2024 Awards Reserved for Issuance Awards Exercised Awards Outstanding Awards Available for Grant 2016 Equity Incentive Plan 2,000,000 — 2,489 1,997,511 2018 Equity Incentive Plan 43,976,425 40,221 245,871 43,690,333 2019 Equity Incentive Plan 55,000,000 349 119,992 54,879,659 Stock-Based Compensation Expense The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses: (in thousands, except for shares / options) For the Three Months Ended March 31, 2024 March 31, 2023 Number of Number of Shares or Stock-Based Shares or Stock-Based Options Compensation Options Compensation Type of Award Granted Expense Granted Expense Stock Options — $ 110 — $ 99 Stock Grants: Employees (Common Stock) — — — — Directors (Common Stock) — — — — Non–Employee Consultants (Common Stock) — — 161,812 356 Total Stock Based Compensation Expense $ 110 $ 455 Stock Options The following table summarizes the Company’s stock option activity and related information for the three March 31, 2024 Weighted- Aggregate Average Intrinsic Weighted- Remaining Value of Number of Average Exercise Contractual In-the-Money Shares Price Per Share Life (in years) Options Options Outstanding as of January 1, 2024 369,301 $ 13.00 Options Outstanding as of March 31, 2024 369,301 $ 12.58 8.0 years $ — Options Exercisable as of March 31, 2024 360,333 $ 12.57 8.1 years $ — As of March 31, 2024 The Company does not 107 not no

Note 14 - Warrants

Note 14 - Warrants	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Warrants [Text Block]	NOTE 14 WARRANTS The following table summarizes the Company's warrant activity for the three March 31, 2024 Weighted- Average Exercise Warrants Price Warrants Outstanding as of January 1, 2024 1,463,312 $ 6.17 Expired (1,315 ) $ 114.10 Warrants Outstanding as of March 31, 2024 1,461,997 $ 6.07

Note 15 - Discontinued Operatio

Note 15 - Discontinued Operations	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	NOTE 15 DISCONTINUED OPERATIONS Cultivation Operations In October 2023, third October 2022. not 810 842. On December 15, 2023, third no December 31, 2023. January 28, 2024, December 31, 2023, The Company concluded that the exit and disposal of its cultivation operations represented a strategic shift that will have a major effect on the Company's operations and financial results and thus all assets and liabilities allocable to the cultivation operations were classified as discontinued operations. The remaining assets associated with the cultivation operations were measured at the lower of their carrying amount or fair value less costs to sell ("FVLCTS"). Revenue and expenses, gains or losses relating to the discontinuation of cultivation operations were eliminated from profit or loss from the Company’s continuing operations and are shown as a single line item in the consolidated statements of operations for all periods presented. The Company has significant continuing involvement in the cultivation facility in Oakland, California as a result of its sublease agreement which expires on July 31, 2027. three March 31, 2024, Operating results for the discontinued operations were comprised of the following: (in thousands) Three Months Ended March 31, 2024 2023 Total Revenues $ 72 $ 112 Cost of Goods Sold — 82 Gross Profit 72 30 Selling, General & Administrative Expenses 68 48 Income (Loss) from Discontinued Operations Before Provision for Income Taxes 4 (18 ) Provision for Income Tax for Discontinued Operations — — Net Income (Loss) from Discontinued Operations $ 4 $ (18 ) Income (Loss) from Discontinued Operations per Common Share Attributable to Blum Holdings, Inc. Common Stockholders - Basic And Diluted $ 0.00 $ (0.00 ) The carrying amounts of the major classes of assets and liabilities for the discontinued operations are as follows: (in thousands) March 31, 2024 December 31, 2023 Cash $ — $ — Prepaid Expenses and Other Assets 16 12 Property, Equipment and Leasehold Improvements, Net 68 95 Other Assets 1 — Assets Related to Discontinued Operations $ 85 $ 107 Accounts Payable and Accrued Expenses — 100 Liabilities Related to Discontinued Operations $ — $ 100

Note 16 - Segment Information

Note 16 - Segment Information	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	NOTE 16 SEGMENT INFORMATION The Company operates in two (i) Cannabis Retail third . (ii) Cannabis Distribution third For the periods presented, revenue by reportable segments are as follows: (in thousands) Total Revenue % of Total Revenue Three Months Ended March 31, Segment 2024 2023 2024 2023 Cannabis Retail $ 6,762 $ 8,184 99.7 % 95.0 % Cannabis Distribution 20 433 0.3 % 5.0 % Total $ 6,782 $ 8,617 100.0 % 100.0 % For the periods presented, results of operations by reportable segments are as follows: (in thousands) Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Cannabis Cannabis Corporate & Cannabis Cannabis Corporate & Retail Distribution Other Total Retail Distribution Other Total Total Revenues $ 6,762 $ 20 $ — $ 6,782 $ 8,184 $ 433 $ — $ 8,617 Cost of Goods Sold 3,143 31 — 3,174 3,805 118 — 3,923 Gross Profit 3,619 (11 ) — 3,608 4,379 315 — 4,694 Gross Profit % 53.5 % (55.0 )% 53.5 % 72.7 % Selling, General & Administrative Expenses 3,439 52 2,608 6,099 2,458 108 2,983 5,549 Income (Loss) from Operations 180 (63 ) (2,608 ) (2,491 ) 1,921 207 (2,983 ) (855 ) Other Income (Expense): Interest Expense (162 ) — (855 ) (1,017 ) (48 ) — (976 ) (1,024 ) Gain on Extinguishment of Debt — — — — — — 3,026 3,026 Realized Loss on Investments — — — — — — (61 ) (61 ) Unrealized Gain on Investments — — 417 417 — — — — Other Income (Expense) 28 — 60 88 — — — — Total Other Income (Expense), Net (134 ) — (378 ) (512 ) (48 ) — 1,989 1,941 Income (Loss) Before Provision for Income Taxes $ 46 $ (63 ) $ (2,986 ) $ (3,003 ) $ 1,873 $ 207 $ (994 ) $ 1,086 Total Assets $ 13,121 $ 894 $ 17,948 $ 31,963 $ 19,882 $ 4,290 $ 15,294 $ 39,466

Note 17 - Related Party Transac

Note 17 - Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 17 RELATED PARTY TRANSACTIONS All related party transactions are monitored quarterly by the Company and approved by the Audit Committee of the Company's board of directors. Refer to “ Note 11 Notes Payable" During the three March 31, 2024 August 12, 2022, April 1, 2023, $40.00 No three March 31, 2024

Note 18 - Commitments and Conti

Note 18 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 18 COMMITMENTS AND CONTINGENCIES California Operating Licenses The Company’s subsidiaries have operated compliantly and have been eligible for applicable licenses and renewals of those licenses. Litigation and Claims The Company is the subject of lawsuits and claims arising in the ordinary course of business from time to time. The Company reviews any such legal proceedings and claims on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies where the incurrence of a loss is probable and can be reasonably estimated, and it discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued if such disclosure is necessary for the Company’s financial statements to not not two March 31, 2024 Magee v. UMBRLA, Inc. et al. July 21, 2020. January 17, 2024. January 2025. March 31, 2024 Fusion LLF, LLC v. Unrivaled Brands, Inc. June 27, 2022, August 11, 2022, August 5, 2022, December 8, 2022. People's California, LLC v. Unrivaled Brands, Inc. July 19, 2022, September 20, 2022, November 2021. March 6, 2023, Note 11 Notes Payable People's California, LLC v. Kovacevich, et al - August 1, 2022, not March 6, 2023, 1149 Unrivaled Brands, Inc. January 30, 2023, 1149 1135 April 10, 2023, October 31, 2023, No March 31, 2024 Greenlane Holdings, LLC v. Unrivaled Brands, Inc. February 6, 2023, April 10, 2023, May 10, 2024. no no WGS Group, Inc. v. Unrivaled Brands, Inc. - July 17, 2023, 17200 no no Dominion Capital LLC and M2B September 28, 2023, M2B November 15, 2023, No ’ s Riverside, LLC and Unrivaled Brands, Inc. - July 21, 2023, No September 13, 2023, no no Glaser Weil Fink Howard Jordan & Shapiro LLP v. Unrivaled Brands, Inc. January 19, 2024, March 12, 2024, no no City of Santa Ana Cannabis Business Tax October 2023, January 1, 2018 May 31, 2021. March 31, 2024

Note 19 - Subsequent Events

Note 19 - Subsequent Events	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 19 SUBSEQUENT EVENTS The Company has evaluated subsequent events through May 14, 2024 During April 2024, January 1, 2018 May 31, 2021 On May 1, 2024, February 9, 2024 42 may On May 1, 2024, 100% not On May 1, 2024, April 26, 2025 12 not

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	5. None.
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and with the instructions to U.S. Securities and Exchange Commission (“SEC”) Form 10 10 X 1933 810, Consolidation, The typical condition for a controlling financial interest ownership is holding a majority of the voting interests of an entity; however, a controlling financial interest may not 810 not not All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of March 31, 2024 December 31, 2023 March 31, 2024 2023 not December 31, 2023 December 31, 2023 December 31, 2023 not
Going Concern [Policy Text Block]	Going Concern The Company incurred a pre-tax net loss from continuing operations of $3.0 million for the three March 31, 2024 three March 31, 2023 March 31, 2024 December 31, 2023 March 31, 2024 2024 may not no The Company will be required to raise additional funds through public or private financing, additional collaborative relationships or other arrangements until it is able to raise revenues to a point of positive cash flow. The Company is evaluating various options to further reduce its cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling common stock. There is no The issuance of additional securities may no not not The risks and uncertainties surrounding the Company's ability to continue to raise capital and its limited capital resources raise substantial doubt as to the Company's ability to continue as a going concern for twelve The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. In an effort to achieve liquidity that would be sufficient to meet all of its commitments, the Company has undertaken a number of actions, including minimizing capital expenditures and reducing recurring expenses. However, management believes that even after taking these actions, the Company will not
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the dates of the financial statements and the reported amounts of total net revenue and expenses in the reporting periods. The Company regularly evaluates estimates and assumptions related to revenue recognition, inventory valuation, stock-based compensation expense, goodwill and purchased intangible asset valuations, derivative liabilities, deferred income tax asset valuation allowances, uncertain tax positions, tax contingencies, litigation and other loss contingencies. These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenue, costs and expenses that are not may
Earnings Per Share, Policy [Policy Text Block]	Income and Loss Per Common Share In accordance with the provisions of ASC 260, Earnings Per Share , not three March 31, 2024 2023 three March 31, 2023 Dilutive securities that are not Three Months Ended March 31, 2024 2023 Common Stock Warrants 1,461,997 1,011,618 Common Stock Options 369,301 433,316 1,831,298 1,444,934
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Standards In June 2022, 2022 03, Fair Value Measurements Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820 2022 03 not not December 15, 2023, January 1, 2024 not Recently Issued Accounting Standards In July 2023, 2023 03, Presentation of Financial Statement (Topic 205 220 480 505 718 No. 120, not no In October 2023, 2023 06, Disclosure Improvements X 2023 06 X not In November 2023, 2023 07, Segment Reporting (Topic 280 280 December 15, 2023, December 15, 2024. In December 2023, 2023 09, Income Taxes (Topic 740 December 15, 2024.

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended March 31, 2024 2023 Common Stock Warrants 1,461,997 1,011,618 Common Stock Options 369,301 433,316 1,831,298 1,444,934

Note 4 - Inventory (Tables)

Note 4 - Inventory (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	(in thousands) March 31, December 31, 2024 2023 Raw Materials $ 642 $ 647 Finished Goods 1,021 1,053 Total Inventory $ 1,663 $ 1,700

Note 5 - Investments (Tables)

Note 5 - Investments (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	(in thousands) March 31, 2024 Amount Level 1 Level 2 Level 3 Investment in Mystic Holdings, Inc. $ 1,083 $ 1,083 $ — $ — Total $ 1,083 $ 1,083 $ — $ — (in thousands) December 31, 2023 Amount Level 1 Level 2 Level 3 Investment in Mystic Holdings, Inc. $ 667 $ 667 $ — $ — Total $ 667 $ 667 $ — $ —

Note 6 - Property, Equipment _2

Note 6 - Property, Equipment and Leasehold Improvements (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Property, Plant and Equipment [Table Text Block]	(in thousands) March 31, December 31, 2024 2023 Land and Building $ 7,581 $ 7,581 Furniture and Equipment 354 354 Computer Hardware 343 343 Leasehold Improvements 5,495 5,487 Vehicles 57 57 Construction in Progress 908 908 Subtotal 14,738 14,730 Less Accumulated Depreciation (5,048 ) (4,964 ) Property, Equipment and Leasehold Improvements, Net $ 9,690 $ 9,766

Note 7 - Intangible Assets (Tab

Note 7 - Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Finite-Lived and Indefinite-lived Intangible Assets [Table Text Block]	(in thousands) March 31, 2024 December 31, 2023 Estimated Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Carrying Value Gross Carrying Amount Accumulated Amortization Net Carrying Value Amortizing Intangible Assets: Trademarks and Patent 2 to 8 $ 4,500 $ (4,500 ) $ — $ 4,500 $ (4,491 ) $ 9 Total Amortizing Intangible Assets 4,500 (4,500 ) — 4,500 (4,491 ) 9 Non-Amortizing Intangible Assets: Trade Name Indefinite 1,350 — 1,350 1,350 — 1,350 Total Non-Amortizing Intangible Assets 1,350 — 1,350 1,350 — 1,350 Total Intangible Assets, Net $ 5,850 $ (4,500 ) $ 1,350 $ 5,850 $ (4,491 ) $ 1,359

Note 9 - Accounts Payable and_2

Note 9 - Accounts Payable and Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	(in thousands) March 31, December 31, 2024 2023 Accounts Payable $ 14,606 $ 13,848 Tax Liabilities 2,584 1,445 Accrued Payroll and Benefits 273 494 Current Lease Liabilities 1,963 1,914 Accrued Interest 1,953 1,421 Other Accrued Expenses 4,688 4,096 Total Accounts Payable and Accrued Expenses $ 26,067 $ 23,218

Note 10 - Leases (Tables)

Note 10 - Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Lease ROU Assets and Lease Liabilities [Table Text Block]	(in thousands) March 31, December 31, 2024 2023 Operating Lease Right-of-Use Assets $ 8,508 $ 8,965 Operating Lease Liabilities $ 10,235 $ 10,536
Schedule of Weighted Average Remaining Lease Term and Discount Rate for Operating Leases [Table Text Block]	Three Months Ended March 31, March 31, 2024 2023 Weighted Average Remaining Lease Term (Years) 8.3 8.6 Weighted Average Discount Rate 11.4 % 11.4 %

Note 11 - Notes Payable (Tables

Note 11 - Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Debt [Table Text Block]	(in thousands) March 31, December 31, 2024 2023 Promissory note dated July 27, 2021, issued to Arthur Chan, which matures July 26, 2024 8 $ 2,500 $ 2,500 Unsecured promissory note dated December 28, 2022 due to a related party. The interest rate on the note is 1 December 28, 2027 154 154 Promissory note dated October 1, 2021, issued to Matthew Guild as part of the SilverStreak Solutions acquisition. The interest rate on the note was 10.0 March 2028 261 264 Promissory note dated October 1, 2021, issued to Sterling Harlan as part of the SilverStreak Solutions acquisition. The interest rate on the note was 10.0 March 2028 1,044 1,058 Secured promissory notes dated March 6, 2023 issued to People's California, LLC, which matures in March 2028 10.0 5.0 10.0 22,200 22,200 Promissory note dated May 1, 2019, assumed by the Company on July 1, 2021 in connection with the purchase of real property, from a related party. The note matures on May 15, 2039 9.9 2,794 2,813 Notes Payable - Promissory Notes 28,953 28,989 Vehicle Loans 6 7 Less: Short-Term Debt (22,573 ) (22,593 ) Plus: Debt Premium, Net 86 82 Net Long-Term Debt $ 6,472 $ 6,485

Note 13 - Stock-based Compens_2

Note 13 - Stock-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]	Awards Reserved for Issuance Awards Exercised Awards Outstanding Awards Available for Grant 2016 Equity Incentive Plan 2,000,000 — 2,489 1,997,511 2018 Equity Incentive Plan 43,976,425 40,221 245,871 43,690,333 2019 Equity Incentive Plan 55,000,000 349 119,992 54,879,659
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]	(in thousands, except for shares / options) For the Three Months Ended March 31, 2024 March 31, 2023 Number of Number of Shares or Stock-Based Shares or Stock-Based Options Compensation Options Compensation Type of Award Granted Expense Granted Expense Stock Options — $ 110 — $ 99 Stock Grants: Employees (Common Stock) — — — — Directors (Common Stock) — — — — Non–Employee Consultants (Common Stock) — — 161,812 356 Total Stock Based Compensation Expense $ 110 $ 455
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted- Aggregate Average Intrinsic Weighted- Remaining Value of Number of Average Exercise Contractual In-the-Money Shares Price Per Share Life (in years) Options Options Outstanding as of January 1, 2024 369,301 $ 13.00 Options Outstanding as of March 31, 2024 369,301 $ 12.58 8.0 years $ — Options Exercisable as of March 31, 2024 360,333 $ 12.57 8.1 years $ —

Note 14 - Warrants (Tables)

Note 14 - Warrants (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Weighted- Average Exercise Warrants Price Warrants Outstanding as of January 1, 2024 1,463,312 $ 6.17 Expired (1,315 ) $ 114.10 Warrants Outstanding as of March 31, 2024 1,461,997 $ 6.07

Note 15 - Discontinued Operat_2

Note 15 - Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Disposal Groups, Including Discontinued Operations [Table Text Block]	(in thousands) Three Months Ended March 31, 2024 2023 Total Revenues $ 72 $ 112 Cost of Goods Sold — 82 Gross Profit 72 30 Selling, General & Administrative Expenses 68 48 Income (Loss) from Discontinued Operations Before Provision for Income Taxes 4 (18 ) Provision for Income Tax for Discontinued Operations — — Net Income (Loss) from Discontinued Operations $ 4 $ (18 ) Income (Loss) from Discontinued Operations per Common Share Attributable to Blum Holdings, Inc. Common Stockholders - Basic And Diluted $ 0.00 $ (0.00 ) (in thousands) March 31, 2024 December 31, 2023 Cash $ — $ — Prepaid Expenses and Other Assets 16 12 Property, Equipment and Leasehold Improvements, Net 68 95 Other Assets 1 — Assets Related to Discontinued Operations $ 85 $ 107 Accounts Payable and Accrued Expenses — 100 Liabilities Related to Discontinued Operations $ — $ 100

Note 16 - Segment Information (

Note 16 - Segment Information (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	(in thousands) Total Revenue % of Total Revenue Three Months Ended March 31, Segment 2024 2023 2024 2023 Cannabis Retail $ 6,762 $ 8,184 99.7 % 95.0 % Cannabis Distribution 20 433 0.3 % 5.0 % Total $ 6,782 $ 8,617 100.0 % 100.0 % (in thousands) Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Cannabis Cannabis Corporate & Cannabis Cannabis Corporate & Retail Distribution Other Total Retail Distribution Other Total Total Revenues $ 6,762 $ 20 $ — $ 6,782 $ 8,184 $ 433 $ — $ 8,617 Cost of Goods Sold 3,143 31 — 3,174 3,805 118 — 3,923 Gross Profit 3,619 (11 ) — 3,608 4,379 315 — 4,694 Gross Profit % 53.5 % (55.0 )% 53.5 % 72.7 % Selling, General & Administrative Expenses 3,439 52 2,608 6,099 2,458 108 2,983 5,549 Income (Loss) from Operations 180 (63 ) (2,608 ) (2,491 ) 1,921 207 (2,983 ) (855 ) Other Income (Expense): Interest Expense (162 ) — (855 ) (1,017 ) (48 ) — (976 ) (1,024 ) Gain on Extinguishment of Debt — — — — — — 3,026 3,026 Realized Loss on Investments — — — — — — (61 ) (61 ) Unrealized Gain on Investments — — 417 417 — — — — Other Income (Expense) 28 — 60 88 — — — — Total Other Income (Expense), Net (134 ) — (378 ) (512 ) (48 ) — 1,989 1,941 Income (Loss) Before Provision for Income Taxes $ 46 $ (63 ) $ (2,986 ) $ (3,003 ) $ 1,873 $ 207 $ (994 ) $ 1,086 Total Assets $ 13,121 $ 894 $ 17,948 $ 31,963 $ 19,882 $ 4,290 $ 15,294 $ 39,466

Note 1 - Description of Busin_2

Note 1 - Description of Business (Details Textual)	Jan. 12, 2024 $ / shares	Mar. 31, 2024 $ / shares	Dec. 31, 2023 $ / shares	Dec. 31, 2022 $ / shares
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.001	$ 0.001	$ 0.001
Preferred Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.001	$ 0.001
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	100
Series V Preferred Stock [Member]
Preferred Stock, Convertible, Conversion Ratio	1
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.001			$ 0.001
Series V Preferred Stock [Member] | Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	10

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ (3,003)	$ 1,086
Retained Earnings (Accumulated Deficit)	(457,230)		$ (454,179)
Cash and Cash Equivalents, at Carrying Value	$ 1,175		$ 862
Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements (in shares)	185,886

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies - Antidilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive securities (in shares)	1,831,298	1,444,934
Warrant [Member]
Antidilutive securities (in shares)	1,461,997	1,011,618
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)	369,301	433,316

Note 3 - Concentrations of Bu_2

Note 3 - Concentrations of Business and Credit Risk (Details Textual) Pure in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023	Dec. 31, 2023 USD ($)
Cash, Uninsured Amount	$ 0		$ 0
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]
Number of Major Customers	0	0
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member]
Number of Vendors	0	0

Note 4 - Inventory - Schedule o

Note 4 - Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Raw Materials	$ 642	$ 647
Finished Goods	1,021	1,053
Total Inventory	$ 1,663	$ 1,700

Note 5 - Investments (Details T

Note 5 - Investments (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Sep. 12, 2023
Unrealized Gain (Loss) on Investments	$ 417	$ 0
Mystic Holdings, Inc. [Member]
Investment Owned, Fair Value	1,080
Unrealized Gain (Loss) on Investments	$ 420
Mystic Holdings, Inc. [Member] | Common Stock [Member]
Investment Owned, Balance, Shares (in shares)			8,323,764
Mystic Holdings, Inc. [Member] | Series A Preferred Stock [Member]
Investment Owned, Balance, Shares (in shares)			8,332

Note 5 - Investments - Schedule

Note 5 - Investments - Schedule of Investments by Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Investments, fair value	$ 1,083	$ 667
Fair Value, Inputs, Level 1 [Member]
Investments, fair value	1,083	667
Fair Value, Inputs, Level 2 [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 3 [Member]
Investments, fair value	0	0
Mystic Holdings, Inc. [Member]
Investments, fair value	1,083	667
Mystic Holdings, Inc. [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, fair value	1,083	667
Mystic Holdings, Inc. [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, fair value	0	0
Mystic Holdings, Inc. [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, fair value	$ 0	$ 0

Note 6 - Property, Equipment _3

Note 6 - Property, Equipment and Leasehold Improvements (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Depreciation	$ 90	$ 120

Note 6 - Property, Equipment _4

Note 6 - Property, Equipment and Leasehold Improvements - Schedule of Property, Equipment and Leasehold Improvements (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Property, Equipment and Leasehold Improvements, Gross	$ 14,738	$ 14,730
Less Accumulated Depreciation	(5,048)	(4,964)
Property, Equipment and Leasehold Improvements, Net	9,690	9,766
Land and Building [Member]
Property, Equipment and Leasehold Improvements, Gross	7,581	7,581
Furniture and Fixtures [Member]
Property, Equipment and Leasehold Improvements, Gross	354	354
Computer Equipment [Member]
Property, Equipment and Leasehold Improvements, Gross	343	343
Leasehold Improvements [Member]
Property, Equipment and Leasehold Improvements, Gross	5,495	5,487
Vehicles [Member]
Property, Equipment and Leasehold Improvements, Gross	57	57
Construction in Progress [Member]
Property, Equipment and Leasehold Improvements, Gross	$ 908	$ 908

Note 7 - Intangible Assets (Det

Note 7 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Amortization of Intangible Assets	$ 10	$ 560

Note 7 - Intangible Assets - Sc

Note 7 - Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Amortizing intangible assets, gross	$ 4,500	$ 4,500
Amortizing intangible assets, accumulated amortization	(4,500)	(4,491)
Amortizing intangible assets, net	0	9
Non-Amortizing intangible assets	1,350	1,350
Total Intangible Assets, gross	5,850	5,850
Total Intangible Assets, Net	1,350	1,359
Trade Names [Member]
Non-Amortizing intangible assets	1,350	1,350
Trademark and Patent [Member]
Amortizing intangible assets, gross	4,500	4,500
Amortizing intangible assets, accumulated amortization	(4,500)	(4,491)
Amortizing intangible assets, net	$ 0	$ 9
Trademark and Patent [Member] | Minimum [Member]
Useful life, intangible assets (Year)	2 years
Trademark and Patent [Member] | Maximum [Member]
Useful life, intangible assets (Year)	8 years

Note 8 - Goodwill (Details Text

Note 8 - Goodwill (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Goodwill	$ 3,585	$ 3,585

Note 9 - Accounts Payable and_3

Note 9 - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounts Payable	$ 14,606	$ 13,848
Tax Liabilities	2,584	1,445
Accrued Payroll and Benefits	273	494
Current Lease Liabilities	1,963	1,914
Accrued Interest	1,953	1,421
Other Accrued Expenses	4,688	4,096
Total Accounts Payable and Accrued Expenses	$ 26,067	$ 23,218

Note 10 - Leases (Details Textu

Note 10 - Leases (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Operating Lease, Cost	$ 680	$ 510
Operating Lease, Liability, Current	$ 1,963		$ 1,914

Note 10 - Leases - Assets and L

Note 10 - Leases - Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Operating Lease Right-of-Use Assets	$ 8,508	$ 8,965
Operating Lease Liabilities	$ 10,235	$ 10,536

Note 10 - Leases - Weighted Ave

Note 10 - Leases - Weighted Average Remaining Lease Term and Discount Rate (Details)	Mar. 31, 2024	Mar. 31, 2023
Weighted Average Remaining Lease Term (Years) (Year)	8 years 3 months 18 days	8 years 7 months 6 days
Weighted Average Discount Rate	11.40%	11.40%

Note 11 - Notes Payable (Detail

Note 11 - Notes Payable (Details Textual) - USD ($)		1 Months Ended
	Jul. 06, 2023	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument, Unamortized Discount (Premium), Net			$ (86,000)	$ (82,000)
Settlement Note [Member]
Debt Instrument, Periodic Payment, Principal	$ 2,200,000
Debt Instrument, Periodic Payment, Interest		$ 25,000
Long-Term Debt			22,200,000
Debt Instrument, Unamortized Discount (Premium), Net			$ (90,000)

Note 11 - Notes Payable - Sched

Note 11 - Notes Payable - Schedule of Notes Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Less: Short-Term Debt	$ (22,573)	$ (22,593)
Plus: Debt Premium, Net	86	82
Net Long-Term Debt	6,472	6,485
Promissory Note Dated July 27, 2021 [Member]
Debt, gross	2,500	2,500
Unsecured Promissory Note Dated December 28, 2022 [Member]
Debt, gross	154	154
First Promissory Note Dated October 1, 2021 [Member]
Debt, gross	261	264
Promissory Note Dated October 1, 2021 [Member]
Debt, gross	1,044	1,058
Secured Promissory Notes Dated March 6, 2023 [Member]
Debt, gross	22,200	22,200
Promissory Note Dated May 1, 2019 [Member]
Debt, gross	2,794	2,813
Notes Payable, Promissory Notes [Member]
Debt, gross	28,953	28,989
Vehicle Loans [Member]
Debt, gross	$ 6	$ 7

Note 11 - Notes Payable - Sch_2

Note 11 - Notes Payable - Schedule of Notes Payable (Details) (Parentheticals)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Promissory Note Dated July 27, 2021 [Member]
Maturity date	Jul. 26, 2024	Jul. 26, 2024
Interest rate	8%	8%
Unsecured Promissory Note Dated December 28, 2022 [Member]
Maturity date	Dec. 28, 2027	Dec. 28, 2027
Interest rate	1%	1%
First Promissory Note Dated October 1, 2021 [Member]
Maturity date	Mar. 31, 2028	Mar. 31, 2028
Interest rate	10%	10%
Promissory Note Dated October 1, 2021 [Member]
Maturity date	Mar. 31, 2028	Mar. 31, 2028
Interest rate	10%	10%
Secured Promissory Notes Dated March 6, 2023 [Member]
Maturity date	Mar. 31, 2028	Mar. 31, 2028
Interest, First 3M	10%	10%
Interest, September 2023	5%	5%
Interest, thereafter	10%	10%
Promissory Note Dated May 1, 2019 [Member]
Maturity date	May 15, 2039	May 15, 2039
Interest rate	9.90%	9.90%

Note 12 - Stockholders' Defic_2

Note 12 - Stockholders' Deficit (Details Textual) $ / shares in Units, $ in Thousands		1 Months Ended
	Jan. 12, 2024 $ / shares	Jan. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 $ / shares shares	Mar. 31, 2024 $ / shares shares	Dec. 31, 2023 $ / shares shares	Feb. 28, 2023 $ / shares shares
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares				$ 0.001	$ 0.001
Preferred Stock, Shares Authorized (in shares)				25,000,000	25,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares				$ 6.07	$ 6.17
Proceeds from Issuance or Sale of Equity | $		$ 1,970
Common Stock, Shares Authorized (in shares)				990,000,000	990,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares	$ 0.001			$ 0.001	$ 0.001
Common Stock, Shares, Outstanding (in shares)				8,499,105	8,509,384
Warrants to Purchase Common Stock [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		703,572
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 2.8
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	100
Series V Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares	$ 0.001		$ 0.001
Preferred Stock, Shares Authorized (in shares)			25,000,000
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)			10
Convertible Preferred Stock, Lock-up Period (Year)			1 year
Preferred Stock, Voting Rights, Multiplication			2
Preferred Stock, Voting Rights, Expiration Period (Year)			2 years
Stock Issued During Period, Shares, New Issues (in shares)		14,071,431
Shares Issued, Price Per Share (in dollars per share) | $ / shares		$ 0.14
Preferred Stock, Convertible, Conversion Price (in dollars per share) | $ / shares		$ 1.4
Series V Preferred Stock [Member] | Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	10
Series N Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares						$ 0.001
Preferred Stock, Shares Authorized (in shares)						2,500,000
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)						100
Series N Preferred Stock [Member] | Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	1

Note 13 - Stock-based Compens_3

Note 13 - Stock-based Compensation (Details Textual) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 150
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	1 year

Note 13 - Stock-based Compens_4

Note 13 - Stock-based Compensation - Summary of Share-based Compensation Arrangements (Details)	3 Months Ended
	Mar. 31, 2024 shares
Equity Incentive Plan 2016 [Member]
Awards Reserved for Issuance (in shares)	2,000,000
Awards Exercised (in shares)	0
Awards Outstanding (in shares)	2,489
Awards Available for Grant (in shares)	1,997,511
Equity Incentive Plan 2018 [Member]
Awards Reserved for Issuance (in shares)	43,976,425
Awards Exercised (in shares)	40,221
Awards Outstanding (in shares)	245,871
Awards Available for Grant (in shares)	43,690,333
Equity Incentive Plan 2019 [Member]
Awards Reserved for Issuance (in shares)	55,000,000
Awards Exercised (in shares)	349
Awards Outstanding (in shares)	119,992
Awards Available for Grant (in shares)	54,879,659

Note 13 - Stock-based Compens_5

Note 13 - Stock-based Compensation - Schedule of Compensation Cost for Share-based Compensation Arrangement (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Stock- Based Compensation Expense	$ 110	$ 455
Director [Member]
Number of Shares or Options Granted (in shares)	0	0
Stock- Based Compensation Expense	$ 0	$ 0
Share-Based Payment Arrangement, Employee [Member]
Number of Shares or Options Granted (in shares)	0	0
Stock- Based Compensation Expense	$ 0	$ 0
Share-Based Payment Arrangement, Nonemployee [Member]
Number of Shares or Options Granted (in shares)	0	161,812
Stock- Based Compensation Expense	$ 0	$ 356
Share-Based Payment Arrangement, Option [Member]
Number of Shares or Options Granted (in shares)	0	0
Stock- Based Compensation Expense	$ 110	$ 99

Note 13 - Stock-based Compens_6

Note 13 - Stock-based Compensation - Summary of Stock Options Activity (Details)	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Options Outstanding, Number (in shares) | shares	369,301
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 13
Options Outstanding, Number (in shares) | shares	369,301
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 12.58
Options Outstanding, Weighted Average Remaining Contractual Term (Year)	8 years
Options Exercisable, Number (in shares) | shares	360,333
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 12.57
Options Exercisable, Weighted Average Remaining Contractual Term (Year)	8 years 1 month 6 days
Options Exercisable, Intrinsic Value | $	$ 0

Note 14 - Warrants - Summary of

Note 14 - Warrants - Summary of Warrants Activity (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Warrants Outstanding, warrants (in shares) | shares	1,463,312
Warrants Outstanding, Exercise Price (in dollars per share) | $ / shares	$ 6.17
Expired, warrants (in shares) | shares	(1,315)
Expired, Exercise Price (in dollars per share) | $ / shares	$ 114.1
Warrants Outstanding, warrants (in shares) | shares	1,461,997
Warrants Outstanding, Exercise Price (in dollars per share) | $ / shares	$ 6.07

Note 15 - Discontinued Operat_3

Note 15 - Discontinued Operations (Details Textual) - Cultivation Facility in Oakland, California [Member] - Discontinued Operations, Disposed of by Sale [Member] - USD ($)		3 Months Ended
	Jan. 28, 2024	Mar. 31, 2024	Dec. 31, 2023	Dec. 15, 2023
Disposal Group, Percentage of Stock and Assets to be Sold				100%
Disposal Group, Including Discontinued Operation, Consideration	$ 1,400,000
Deposit Assets			$ 100,000
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax	$ 100,000
Discontinued Operation, Amount of Continuing Cash Inflows after Disposal		$ 72,000
Discontinued Operation, Amount of Continuing Cash Outflows after Disposal		$ 50,000

Note 15 - Discontinued Operat_4

Note 15 - Discontinued Operations - Income Statement and Balance Sheet Disclosure (Details) - USD ($) $ / shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Total Revenues	$ 72	$ 112
Cost of Goods Sold	0	82
Gross Profit	72	30
Selling, General & Administrative Expenses	68	48
Income (Loss) from Discontinued Operations Before Provision for Income Taxes	4	(18)
Provision for Income Tax for Discontinued Operations	0	0
Net Income (Loss) from Discontinued Operations	$ 4	$ (18)
Income (Loss) from Discontinued Operations per Common Share Attributable to Blum Holdings, Inc. Common Stockholders - Basic And Diluted (in dollars per share)	$ 0	$ 0
Cash	$ 0		$ 0
Prepaid Expenses and Other Assets	16		12
Property, Equipment and Leasehold Improvements, Net	68		95
Other Assets	1		0
Assets Related to Discontinued Operations	85		107
Accounts Payable and Accrued Expenses	0		100
Liabilities Related to Discontinued Operations	$ 0		$ 100

Note 16 - Segment Information_2

Note 16 - Segment Information (Details Textual)	3 Months Ended
	Mar. 31, 2024
Number of Operating Segments	2

Note 16 - Segment Information -

Note 16 - Segment Information - Schedule of Segment Reporting Information by Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenues	$ 6,782	$ 8,617
Revenue	6,782	8,617
Cost of Goods Sold	3,174	3,923
Gross Profit	$ 3,608	$ 4,694
Gross Profit %
Selling, General & Administrative	$ 6,099	$ 5,549
Loss from Operations	(2,491)	(855)
Interest Expense, Net	(1,017)	(1,024)
Gain on Extinguishment of Debt	0	3,026
Realized Loss on Investments	0	(61)
Unrealized Gain on Long-Term Investments	417	0
Other Income	88	0
Total Other Income (Expense)	(512)	1,941
Income (Loss) from Continuing Operations Before Provision for Income Taxes	(3,003)	1,086
Total Assets	31,963	39,466	$ 32,071
Cannabis Retail [Member]
Revenues	6,762	8,184
Revenue	6,762	8,184
Cost of Goods Sold	3,143	3,805
Gross Profit	$ 3,619	$ 4,379
Gross Profit %	53.50%	53.50%
Selling, General & Administrative	$ 3,439	$ 2,458
Loss from Operations	180	1,921
Interest Expense, Net	(162)	(48)
Gain on Extinguishment of Debt	0	0
Realized Loss on Investments	0	0
Unrealized Gain on Long-Term Investments	0	0
Other Income	28	0
Total Other Income (Expense)	(134)	(48)
Income (Loss) from Continuing Operations Before Provision for Income Taxes	46	1,873
Total Assets	$ 13,121	$ 19,882
Cannabis Retail [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]
Concentration Risk, Percentage	99.70%	95%
Cannabis Cultivation and Distributions [Member]
Revenues	$ 20	$ 433
Revenue	20	433
Cost of Goods Sold	31	118
Gross Profit	$ (11)	$ 315
Gross Profit %	(55.00%)	72.70%
Selling, General & Administrative	$ 52	$ 108
Loss from Operations	(63)	207
Interest Expense, Net	0	0
Gain on Extinguishment of Debt	0	0
Realized Loss on Investments	0	0
Unrealized Gain on Long-Term Investments	0	0
Other Income	0	0
Total Other Income (Expense)	0	0
Income (Loss) from Continuing Operations Before Provision for Income Taxes	(63)	207
Total Assets	$ 894	$ 4,290
Cannabis Cultivation and Distributions [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]
Concentration Risk, Percentage	0.30%	5%
Corporate Segment and Other Operating Segment [Member]
Revenue	$ 0	$ 0
Cost of Goods Sold	0	0
Gross Profit	$ 0	$ 0
Gross Profit %
Selling, General & Administrative	$ 2,608	$ 2,983
Loss from Operations	(2,608)	(2,983)
Interest Expense, Net	(855)	(976)
Gain on Extinguishment of Debt	0	3,026
Realized Loss on Investments	0	(61)
Unrealized Gain on Long-Term Investments	417	0
Other Income	60	0
Total Other Income (Expense)	(378)	1,989
Income (Loss) from Continuing Operations Before Provision for Income Taxes	(2,986)	(994)
Total Assets	$ 17,948	$ 15,294
All Segments [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]
Concentration Risk, Percentage	100%	100%

Note 17 - Related Party Trans_2

Note 17 - Related Party Transactions (Details Textual) - Adnant, LLC [Member] - Engagement Letter [Member] - USD ($) $ in Thousands		3 Months Ended
	Apr. 01, 2023	Mar. 31, 2024
Related Party Transaction, Amounts of Transaction	$ 200	$ 600
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding	2,500
Compensation, Transaction Bonus Amount	$ 1,250

Note 18 - Commitments and Con_2

Note 18 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands										1 Months Ended
	Jan. 19, 2024	Oct. 31, 2023	Sep. 28, 2023	Jul. 21, 2023	Feb. 06, 2023	Jan. 30, 2023	Sep. 20, 2022	Jul. 19, 2022	Jun. 27, 2022	Oct. 30, 2023	Mar. 31, 2024
Minimum [Member]
Loss Contingency, Damages Sought, Value							$ 5,400
Magee vs. UMBRLA, Inc. et al [Member] | Loss Contingency, Breach of Contract [Member]
Loss Contingency Accrual											$ 500
Fusion LLF, LLC vs. Unrivaled Brands, Inc [Member] | Loss Contingency, Breach of Contract, Account Stated, and Writ of Attachment [Member]
Loss Contingency, Damages Sought, Value									$ 4,550
People's California, LLC vs. Unrivaled Brands, Inc [Member] | Loss Contingency, Breach of Contract [Member]
Loss Contingency, Damages Sought, Value								$ 23,000
The 1149 South LA Street Fashion District, LLC v. Unrivaled Brands, Inc [Member]
Loss Contingency, Damages Sought, Value						$ 580
Loss Contingency, Damages Awarded, Value		$ 500
Greenlane Holdings, LLC vs. Unrivaled Brands, Inc [Member] | Loss Contingency, Breach of Contract, Account Stated, and Unjust Enrichment [Member]
Loss Contingency, Damages Sought, Value					$ 400
Dominion Capital LLC and M2B Funding Corp. vs Unrivaled Brands, Inc [Member]
Loss Contingency, Damages Sought, Value			$ 3,030
No Smoking Allowed Except Turn, LLC Litigation [Member]
Loss Contingency, Damages Sought, Value				$ 600
Glaser Weil Fink Howard Jordan & Shapiro LLP v. Unrivaled Brands, Inc. [Member]
Loss Contingency, Damages Sought, Value	$ 280
City of Santa Ana Business Tax Litigation [Member]
Loss Contingency Accrual											$ 1,280
Loss Contingency, Damages Sought, Value										$ 1,280

Note 19 - Subsequent Events (De

Note 19 - Subsequent Events (Details Textual) - USD ($)			12 Months Ended
	May 01, 2025	May 01, 2024	May 01, 2025	Apr. 30, 2024	Mar. 31, 2024
Coastal Pine Holdings, Inc. [Member] | Forecast [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)	393,013		889,725
City of Santa Ana Business Tax Litigation [Member]
Loss Contingency Accrual					$ 1,280,000
Subsequent Event [Member] | Safe Accessible Solutions, Inc. [Member]
Business Acquisition, Percentage of Voting Interests Acquired		100%
Business Combination, Consideration Transferred		$ 1,671,451
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		945,605
Subsequent Event [Member] | Safe Accessible Solutions, Inc. [Member] | Safe Accessible Solutions Note [Member]
Business Combination, Consideration Transferred, Liabilities Incurred		$ 1,000,071
Debt Instrument, Periodic Payment		23,811
Subsequent Event [Member] | Coastal Pine Holdings, Inc. [Member]
Business Combination, Consideration Transferred, Liabilities Incurred		$ 940,974
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		496,712
Support Services, Monthly Fee Receivable		$ 75,000
Subsequent Event [Member] | City of Santa Ana Business Tax Litigation [Member]
Loss Contingency Accrual				$ 400,000